A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 11,503 shares of NTRA stock, worth $1.85 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,503
Previous 11,009 4.49%
Holding current value
$1.85 Million
Previous $1.19 Million 22.65%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$97.75 - $129.67 $48,288 - $64,056
494 Added 4.49%
11,503 $1.46 Million
Q2 2024

Aug 12, 2024

BUY
$85.28 - $112.6 $129,455 - $170,926
1,518 Added 15.99%
11,009 $1.19 Million
Q1 2024

May 09, 2024

BUY
$59.21 - $92.9 $47,486 - $74,505
802 Added 9.23%
9,491 $868,000
Q4 2023

Feb 07, 2024

BUY
$37.55 - $62.64 $39,089 - $65,208
1,041 Added 13.61%
8,689 $544,000
Q3 2023

Nov 08, 2023

SELL
$43.4 - $62.52 $3,732 - $5,376
-86 Reduced 1.11%
7,648 $338,000
Q2 2023

Jul 28, 2023

SELL
$47.08 - $55.16 $4,378 - $5,129
-93 Reduced 1.19%
7,734 $376,000
Q1 2023

May 10, 2023

BUY
$36.57 - $58.29 $16,127 - $25,705
441 Added 5.97%
7,827 $434,000
Q4 2022

Feb 10, 2023

SELL
$34.17 - $47.91 $43,088 - $60,414
-1,261 Reduced 14.58%
7,386 $296,000
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $5,576 - $8,558
151 Added 1.78%
8,647 $379,000
Q2 2022

Aug 09, 2022

BUY
$28.13 - $44.54 $96,063 - $152,104
3,415 Added 67.21%
8,496 $301,000
Q1 2022

May 16, 2022

BUY
$30.32 - $91.33 $154,055 - $464,047
5,081 New
5,081 $207,000
Q4 2021

Feb 23, 2022

SELL
$86.26 - $119.0 $285,434 - $393,771
-3,309 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$100.17 - $126.36 $232,294 - $293,028
-2,319 Reduced 41.2%
3,309 $369,000
Q2 2021

Aug 11, 2021

BUY
$86.05 - $119.72 $484,289 - $673,784
5,628 New
5,628 $639,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.6B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.